Bank of New York Mellon
KERX

Bank of New York Mellon’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bank of New York Mellon’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-987,204
Closed -$3.36M – 4311
2018
Q3 		$3.36M Sell
987,204
-69,607
-7% -$237K ﹤0.01% 2578
2018
Q2 		$3.97M Buy
1,056,811
+102,014
+11% +$384K ﹤0.01% 2507
2018
Q1 		$3.91M Buy
954,797
+10,934
+1% +$44.7K ﹤0.01% 2476
2017
Q4 		$4.39M Sell
943,863
-29,366
-3% -$137K ﹤0.01% 2414
2017
Q3 		$6.91M Buy
973,229
+10,175
+1% +$72.2K ﹤0.01% 2182
2017
Q2 		$6.96M Buy
963,054
+32,687
+4% +$236K ﹤0.01% 2156
2017
Q1 		$5.73M Sell
930,367
-455,019
-33% -$2.8M ﹤0.01% 2262
2016
Q4 		$8.12M Buy
1,385,386
+270,318
+24% +$1.58M ﹤0.01% 2065
2016
Q3 		$5.92M Buy
1,115,068
+169,936
+18% +$903K ﹤0.01% 2152
2016
Q2 		$6.26M Sell
945,132
-67,230
-7% -$445K ﹤0.01% 2091
2016
Q1 		$4.73M Sell
1,012,362
-8,614
-0.8% -$40.2K ﹤0.01% 2208
2015
Q4 		$5.16M Buy
1,020,976
+50,035
+5% +$253K ﹤0.01% 2196
2015
Q3 		$3.42M Sell
970,941
-128,864
-12% -$454K ﹤0.01% 2429
2015
Q2 		$11M Buy
1,099,805
+144,366
+15% +$1.44M ﹤0.01% 1918
2015
Q1 		$12.2M Buy
955,439
+180,764
+23% +$2.3M ﹤0.01% 1841
2014
Q4 		$11M Buy
774,675
+20,435
+3% +$289K ﹤0.01% 1862
2014
Q3 		$10.4M Buy
754,240
+241,470
+47% +$3.32M ﹤0.01% 1875
2014
Q2 		$7.89M Sell
512,770
-22,162
-4% -$341K ﹤0.01% 2068
2014
Q1 		$9.12M Buy
534,932
+40,192
+8% +$685K ﹤0.01% 1957
2013
Q4 		$6.41M Buy
494,740
+5,201
+1% +$67.3K ﹤0.01% 2148
2013
Q3 		$4.94M Buy
489,539
+31,263
+7% +$315K ﹤0.01% 2259
2013
Q2 		$3.42M Buy
+458,276
New +$3.42M ﹤0.01% 2419